Article
Angiotensin-converting enzyme insertion/deletion polymorphism has no effect on the risk of atherosclerotic stroke or hypertension.
Journal of the neurological sciences - 15 Oct 2009
Tascilar N, Dursun A, Ankarali H, Mungan G, Ekem S, Baris S
Abstract excerpt
BACKGROUND AND PURPOSE: Stroke is a heterogeneous multifactorial disease. Hence, a large number of candidate genes are involved in stroke pathophysiology, such as blood pressure regulation and atherosclerosis. Although angiotensin-converting enzyme insertion/deletion (ACE I/D) polymorphism is considered to have a role in hypertension, coronary artery disease, and myocardial infarction, its relationship with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
